A decade of excellent transplant survival in children with inherited metabolic diseases: A report from a single metabolic transplant centre in Europe

Hematopoietic cell transplantation (HCT) confers a long-term disease-modifying therapy for transplant-permissive inherited metabolic diseases (IMDs). We examined the overall survival (OS) and engrafted survival (ES) of children with IMDs, who received first HCT at Royal Manchester Children's ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Lum, Su Han, Will, Andrew, Church, Heather J, Mercer, Jean, Tylee, Karen L, Poulton, Kay, Odgen, Wendy, Lee, Helena, Logan, Alison, Coussons, Mary, Khalid, Tasneem, Bonney, Denise, Rust, Stewart, Hiwarkar, Prashant, Jones, Simon A, Wynn, Robert F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599831/
https://www.ncbi.nlm.nih.gov/pubmed/37885827
http://dx.doi.org/10.31547/bct-2018-012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599831/
https://www.ncbi.nlm.nih.gov/pubmed/37885827
http://dx.doi.org/10.31547/bct-2018-012

Ejemplares similares